Literature DB >> 9822715

The collagenolytic activity of cathepsin K is unique among mammalian proteinases.

P Garnero1, O Borel, I Byrjalsen, M Ferreras, F H Drake, M S McQueney, N T Foged, P D Delmas, J M Delaissé.   

Abstract

Type I collagen fibers account for 90% of the organic matrix of bone. The degradation of this collagen is a major event during bone resorption, but its mechanism is unknown. A series of data obtained in biological models strongly suggests that the recently discovered cysteine proteinase cathepsin K plays a key role in bone resorption. Little is known, however, about the actual action of cathepsin K on type I collagen. Here, we show that the activity of cathepsin K alone is sufficient to dissolve completely insoluble collagen of adult human cortical bone. We found that the collagenolytic activity of cathepsin K is directed both outside the helical region of the molecule, i.e. the typical activity of cysteine proteinases, and at various sites inside the helical region, hitherto believed to resist all mammalian proteinases but the collagenases of the matrix metalloproteinase family and the neutrophil elastase. This property of cathepsin K is unique among mammalian proteinases and is reminiscent of bacterial collagenases. It is likely to be responsible for the key role of cathepsin K in bone resorption.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822715     DOI: 10.1074/jbc.273.48.32347

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  148 in total

Review 1.  Who are the proteolytic culprits in vascular disease?

Authors:  W C Parks
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  A putative role for cathepsin K in degradation of AA and AL amyloidosis.

Authors:  C Röcken; B Stix; D Brömme; S Ansorge; A Roessner; F Bühling
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 3.  ECM roles in the function of metabolic tissues.

Authors:  Guorui Huang; Daniel S Greenspan
Journal:  Trends Endocrinol Metab       Date:  2011-11-08       Impact factor: 12.015

Review 4.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

5.  Effect of ultraviolet A-induced crosslinking on dentin collagen matrix.

Authors:  Roda Seseogullari-Dirihan; Leo Tjäderhane; David H Pashley; Arzu Tezvergil-Mutluay
Journal:  Dent Mater       Date:  2015-08-25       Impact factor: 5.304

Review 6.  Mechanisms regulating the degradation of dentin matrices by endogenous dentin proteases and their role in dental adhesion. A review.

Authors:  Camila Sabatini; David H Pashley
Journal:  Am J Dent       Date:  2014-08       Impact factor: 1.522

Review 7.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

8.  Probing cathepsin K activity with a selective substrate spanning its active site.

Authors:  Fabien Lecaille; Enrico Weidauer; Maria A Juliano; Dieter Brömme; Gilles Lalmanach
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

9.  S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.

Authors:  Marcio F M Alves; Luciano Puzer; Simone S Cotrin; Maria Aparecida Juliano; Luiz Juliano; Dieter Brömme; Adriana K Carmona
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

10.  Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.

Authors:  Linda Chung; Deendayal Dinakarpandian; Naoto Yoshida; Janelle L Lauer-Fields; Gregg B Fields; Robert Visse; Hideaki Nagase
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.